MOVIPREP® Versus NaP Pivotal Phase III Study

NCT00322062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Colonoscopy

Interventions

DRUG: macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate
DRUG: Sodium Phosphate Solution

Sponsor

Norgine